Department of Pediatrics Archive — Page 54 of 58

Portrait of a smiling woman with long brown hair wearing a light-colored top and necklace.
October 17, 2013

Fellow tracks post-vaccination bacterial trends

Pediatric Infectious Diseases fellow Annabelle de St. Maurice, M.D., has been awarded a grant to determine the relationship between pneumococcal vaccination and the emergence of certain strains of pneumococcal bacteria not covered by vaccines.

By Vanderbilt Health News
Two smiling medical professionals seated together in an office, with framed certificates and plaques on the wall behind them. The woman wears an identification badge and a yellow awareness pin.
September 26, 2013

Vaccine Research Program lands major NIH renewal

The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units.

By Vanderbilt Health News
syringe
September 19, 2013

VU testing vaccine against new flu threat

Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring.

By Vanderbilt Health News
White Hyundai vehicle covered with colorful handprints and printed text reading “Hyundai Hope On Wheels,” “Helping kids fight cancer,” and “Proudly Sponsored by Hyundai.” A child using a walker stands beside the vehicle.
September 19, 2013

Hyundai award helps drive hope for cancer research

Emmanuel Volanakis, M.D., assistant professor of Pediatrics and Hematology/Oncology, was awarded a $250,000 Hyundai Hope On Wheels grant last week for his ongoing research into T-cell acute lymphoblastic leukemia (ALL), an aggressive blood cancer.

By Christina Echegaray
Close-up of a hand with a fingertip blood drop held near a blue blood glucose meter displaying a numeric reading.
September 12, 2013

VU tracking drug’s ability to prevent type 1 diabetes

Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.

By Vanderbilt Health News
A curly-haired healthcare provider examines a young red-haired girl’s leg while an older woman looks on in a pediatric clinic room.
September 12, 2013

Options to treat childhood C. diff. infection studied

After more than a month in and out of the hospital with her daughter, Kynslee, Kristen Allen felt she was at the end of her rope. Last spring, the nearly 2-year-old Columbia girl developed diarrhea that wouldn’t go away after taking antibiotics for repeated ear infections.

By Vanderbilt Health News